Shiro Akinaga
Director Ejecutivo en NANO MRNA CO.,LTD. .
Fortuna: 90 589 $ al 30/04/2024
Perfil
Shiro Akinaga is currently the President, CEO & Representative Director at NANO MRNA Co., Ltd.
since 2022.
He is also the Chairman & Chief Executive Officer at AccuRna, Inc. since 2017.
Previously, he worked at Kyowa Kirin Co., Ltd.
as an Executive Officer & Manager-Overseas Development.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NANO MRNA CO.,LTD.
0.11% | 31/03/2023 | 78 760 ( 0.11% ) | 90 589 $ | 30/04/2024 |
Cargos activos de Shiro Akinaga
| Empresas | Cargo | Inicio |
|---|---|---|
| NANO MRNA CO.,LTD. | Director Ejecutivo | 01/12/2022 |
AccuRna, Inc.
 AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Director Ejecutivo | 01/03/2017 |
Antiguos cargos conocidos de Shiro Akinaga.
| Empresas | Cargo | Fin |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| NANO MRNA CO.,LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
AccuRna, Inc.
AccuRna, Inc. BiotechnologyHealth Technology AccuRna, Inc. researches and develops nucleic acid-based drugs using drug delivery system technologies. The company was founded on December 18, 2015 and is headquartered in Tokyo, Japan. | Health Technology |
- Bolsa de valores
- Insiders
- Shiro Akinaga